SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " path " 1,580 found 🔀 AI-powered Shuffle
University of Phoenix opens enrollment for three-year Bachelor of Science in Criminal Justice Administration
University of Phoenix announces that enrollment is now open for its three-year Bachelor of Science in Criminal Justice Administration, a 90-credit online bachelor's degree pathway designed for students with at least three years of work experience in criminal justice or security.
Where do the Cardinals go from here?
Well. Another pathetic showing from a St. Louis Cardinals bullpen resulted in a series sweep against a mediocre opponent. This team has constantly shown it plays to the level of their competition, but the series against the Giants went too far. After winning five of their last six series on the road, including taking the […]
Alabama Adds UAB Transfer With Unusual Path to Tuscaloosa
The Alabama Crimson Tide make an unusual late-season addition ahead of Week 2's matchup against SEC-rival Kentucky.
Leipzig struggle to make progress in David Raum contract talks
With the contract of David Raum only running until 2027, there is naturally a lot of uncertainty regarding his future at RB Leipzig.As it stands, whether their paths either diverge in winter or next s...
The Mathematician Crushed Between OpenAI and Anthropic Over a Math Problem
Tristan Buckmaster was on the path toward an important proof when one of the A.I. giants used its staggering resources to get there first.
Scripps Oceanography and Ocean Science Trust Chart Path to Flood Resilience in California
A new OST and Scripps Institution of Oceanography report offers eight recommendations to improve catastrophe flood modeling and link mitigation efforts to insurance pricing, positioning California as a national leader in coastal flood resilience.
Take Charge of Your Health Today: Safe and affordable housing
JENNIFER THOMPKINS Alzheimer’s disease and other forms of dementia can affect any family, but access to diagnosis, treatment and support is not equal across communities. For many African Americans, the path to care is complicated by limited access to health services, transportation, healthy food, reliable information, and trusted organizations. Those barriers, according to Jennifer Thompkins, president of […]
Autism Decoded: New Science Is Opening Paths to Better Treatments
In the past few decades, researchers have identified hundreds of genes that increase the risk of autism spectrum
Red Bull signs Robin Räikkönen to its Junior Driver Academy
The 15 year old Finn takes a key step in his sporting career by entering the Austrian team's development program. He inherits the legacy of his father, world champion in 2007, and seeks to forge his own path in motorsport.
NH Politics' Primary Math Problems: Dem Extremism, GOP Apathy
New Hampshire - NH Politics' Primary Math Problems: Dem Extremism, GOP Apathy - NH Journal - Politics
World Alzheimer’s Month: How far has science come?
The following expert commentary can be used by journalists and media organizations in their own publications and news coverage. Please attribute all quotes to David Hunter, MD, associate professor at UTHealth Houston and behavioral neurologist and neuropsychiatrist with UT Physicians. Alzheimer’s disease, named for the German pathologist Dr. Alois Alzheimer, is a progressive brain disorder that affects a person’s memory and ability to carry out daily tasks. The number of Americans
How 9/11 changed NYC Council Speaker Julie Menin's life and set her on a path to politics
Tackling the Health Care Interoperability Problem | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Daniel Marshall finds his path in science, one tick at a time
Muscogee citizen Daniel Marshall earned national recognition for his research on Lone Star ticks. Now, he hopes his journey can encourage more Native students to find their place in science.
Dodgers Still Weigh Two Very Different Paths for Sasaki’s Return
As a nagging right middle finger blister heals, the Los Angeles Dodgers must decide if Roki Sasaki serves the postseason run best as a high-intensity reliever or a stabilized rotation anchor.
HHS recognizes Recovery Month, celebrates strength and pathways to recovery | Health and Human Services North Dakota
September is National Recovery Month, as proclaimed by Gov. Kelly Armstrong. The month celebrates people in recovery, the families and communities who support them and the possibility of recovery from mental health and substance use challenges. North Dakota Health and Human Services (HHS) reminds North Dakotans that recovery looks different for everyone, and support is available at every stage of the journey. Read the National Recovery Month proclamation.
UGA’s Buell Grows Discovery and the Next Generation of Scientists
Not the Plan but the Right Path
Beit Yisrael could give Ethiopian Israelis a new path to political influence
Gadi Yevarkan’s new Beit Yisrael party seeks to move Ethiopian Israelis from political inclusion to real power.
Paleontologists discover first adult 'T. rex' footpath
The Cretaceous dinosaur moseyed with a 13-foot-stride.
Jeremy Farrar Joins Global Health Non-Profit PATH Following Unexpected Departure From WHO
Outgoing WHO Assistant Director-General Dr Jeremy Farrar will lead PATH’s regional division for Asia, the Middle East, and Europe starting 1 October. Based in Geneva, he joins the executive leadership team to accelerate the delivery of health technologies across these regions, the organisation announced in a press release on Wednesday, 9 September.
A path toward justice and public safety
Strangulation can be one of the most dangerous forms of assault; despite the lack of visible ailments it is accompanied by. Though strangulation leaves no broken bones, bruises or visible wounds, it is one of the strongest predictors of future homicides for domestic violence victims. Until this year, second-degree assault by strangulation was not classified […]
WA's political leadership pipeline grows as 21 women complete Pathway to Politics
Twenty-one women from across WA have graduated from the 2026 Pathways to Politics for Women program at The University of Western Australia.
New transfer agreements link FVTC business degrees to UW-Oshkosh
Four new pathways cover accounting, finance, business management and marketing
Exclusive: Two of gaming’s biggest names are making a big investment in gaming’s future
The first thing to know about the Nova Games Foundation is that it isn’t about The Game Awards. And it’s not about PlayStation. The ambitious new grant program is the brainchild of Geoff Keighley and Mark Cerny. Keighley is the host of The Game Awards, Summer Game Fest and Opening Night Live. Cerny is a game designer of some 45 years and the lead architect for the PlayStation 4 and 5. But this new thing, which they’re revealing through Game File, isn’t about their day jobs. It’s an unaffiliated, standalone philanthropic project. It’s a bet on the artistic future of video games and a way, they tell me, to give back. “I’m nearing the end of my career,” Cerny recently told me over email. “I’m not done yet, but paying it forward—in the best way possible—is very much on my mind these days,” The Nova Games Foundation is a university-affiliated fellowship program, intended to offer six-figure grants to 20 young game designers each year, potentially for decades to come. It will offer no-strings-attached funding along with mentorship from games industry leaders, a combination intended to aid the development of groundbreaking new games, Cerny and Keighley told me. Nova will begin accepting applications in December, from class of 2026 and 2027 students from 13 affiliated gaming programs at universities in eight countries. The schools working with Nova include the New York University and the University of Southern California in the U.S., along with Abertay University in Scotland, Cnam-Enjmin in France, TH Köln in Germany, and the Royal Melbourne Institute of Technology in Australia, Cerny and Keighley said. The plan: $100,000 per recipient, with about a quarter of Nova fellows eligible for up to $500,000 more for projects that are shaping up particularly well. Payments will be delivered based on development milestones, and recipients will own their games. Nova will help promote the work, and developers will be free to pursue the publishers and platforms of their choice. Nova can help introduce fellows to publishers, but won’t take a cut. “I’ve always wanted to give back, but given my role in the industry, I’ve never felt it appropriate to commercially invest in games,” Keighley told Game File. “I’ve never owned stock in a game company or taken a financial stake in a game. Nova is philanthropy: we aren’t taking equity or looking to recoup the grants. The return we’re hoping for is creative—helping new voices make games and find their footing. “Mark and I have each made multi-million-dollar donations to establish the foundation, and we intend to keep contributing. We hope others will join us.” Cerny and Keighley have already hired an executive director, John Maconga, and a head of grants, recent Game Developers Conference director Ashley Corrigan, to help launch the effort. They’re working to recruit game industry leaders to join the effort. Keighley says “dozens of leading game directors have already expressed interest in contributing their time.” To name one, they’ve already gotten Josef Fares, lead designer from It Takes Two and Spit Fiction studio Hazelight on board with a donation and pledge to help out. “I’m proud to support Nova because it gives the next generation of creators the freedom to explore their creativity and hopefully bring their unique visions to life,” Fares told Game File. A plan forged from a friendship Keighley and Cerny have known each other a long time. It’s been so long, Cerny isn’t even sure exactly when they met. “We travel in much the same circles and I’m sure first intersected in the 90s or early 2000s,“ Cerny said. Keighley thinks it might have been during his stint writing a column about the mid-’90s console 3DO for a gaming magazine while Cerny was working on games with Crystal Dynamics or on Way of the Warrior with Naughty Dog. They became genuine friends about a 10 years ago, Keighley said, as they bonded over a shared love of games and a hope to improve the industry. “About a decade ago, we started having dinner a few times a year in LA,” Keighley said. “Just to catch up on life and the industry. Those conversations continued over Zoom during COVID. Nova grew out of that friendship and a question we kept coming back to: ‘What could we do to help the next generation of game directors get started?’” Keighley credits Cerny with the idea to figure out a way to put their money and time back into the industry. At one of those dinners, Keighley proposed the idea of a fellowship program. He’d recalled applying for a Rhodes Scholarship when he was younger. “Spoiler: I didn’t get it,” he said. He’d admired the MacArthur Foundation’s so-called “genius grants.” He liked these kinds of programs that recognized people’s talents and gave them the financial boost and the freedom to realize their potential. With Cerny, he had pondered what a game industry version of that could be. Keighley liked the idea of centering the fellowship on students, drawing inspiration from the accomplishments of Jenova Chen, the USC game design graduate who went on to lead the creation of gently moving, ambitious games such as Flower and Journey. Keighley also thought it could be useful to help promising graduates bridge the transition from student to professional. “Joining an established studio isn’t always possible—especially in today’s market—and even then, it isn’t the right path for everyone,” Keighley said. A fellowship, he realized, could give “graduates the time, resources and guidance to pursue a game of their own and not worry about the commercial viability.” As the idea took shape, Cerny also saw an opportunity to enable more games of a certain type: “The target with the grants is games as an artistic medium,” Cerny told me. “We like to say games with ‘artistic, literary and societal value.’” He added: “I’m a pretty big gamer myself, though I tend to gravitate towards the smaller and more unique or artistic titles, games like Neva, Abzu, Gorogoa, Stray or Outer Wilds. I was just playing and Roger on a flight to Japan, and was getting misty eyed to a degree that I was concerned that a flight attendant would ask me if I was OK. “So one fun benefit here is the games that will come out of the Nova Games Foundation – I can’t wait to play them myself.” Cerny believes it will also be useful for Nova fellows to hone their craft and team leadership skills. “We are looking for the next generation of visionaries,” he said. “The trick is that they will also need to have the executive function necessary to drive a small project to completion.” Game File is a reader-supported publication. To receive new posts and support my reporting, please consider becoming a free or paid subscriber. Subscribe Going big with this Keighley and Cerny may have started Nova and may be the ones primarily backing it right now, but they’re dreaming of something that goes beyond them. “Mark and I may have helped get it started, but one of our measures of success is that Nova grows into something the entire games industry feels a sense of ownership in,” Keighley said. “Our ambition is to build a lasting endowment supported by people and companies across the industry, and an equally broad community of creators willing to give their time and experience to the next generation.” The industry has a lot of knowledge that it can pass to the next generation, Keighley said: “Nova can hopefully become a way to connect that generosity with talented young creators at the moment when it can make the biggest difference.” Cerny, who told me he believes Nova can mature “over the next 10 or 20 years,” sees an opportunity to give generations of game makers momentum. “The industry has changed immeasurably since I started in games in 1982,” he said. “These graduates have talent, training and tools that outclass what we had back in the day by an astonishing amount. But they face a tough road ahead getting traction in the industry, and many could benefit from our support. We want to be there to give it to them.” “There’s a personal side to this, too,” Keighley said. “I don’t have children, and I’ve spent a lot of time thinking about what I can do for future generations. Games have been my entire career. I’ve been incredibly fortunate, and helping someone else build a life in this industry feels like a meaningful way to give back.” Cerny’s oeuvre dates back to Marble Madness and Sonic the Hedgehog 2. He has stood on stage multiple times to reveal the future of PlayStation hardware. He’s been an executive producer for a string of modern PlayStation classics such as The Last Guardian and Marvel’s Spider-Man. Nevertheless, of Nova, he said, “It’s certainly not like anything I’ve done before.” Nova Foundation applications will be due in December and the first wave of fellows will be announced in March 2027. A full list of participating universities and steps students and recent graduates can take to apply to become a Nova Fellow is forthcoming.
Drug developed for lung disease may slow biological aging in surprising ‘bonus’
Rentosertib, an AI-discovered drug for idiopathic pulmonary fibrosis, made patients appear three to four years biologically younger in a clinical trial.
Scientists Discover Bacteria That Can Make Testosterone Near the Prostate, With Potential Implications for Cancer
A newly discovered bacterial pathway turns a common steroid precursor into testosterone.
Kansas City psychiatrist explores the science behind high emotional sensitivity
Dr. Sasha Hamdani's new book, "Too Sensitive," aims to provide a science-backed, empathetic framework for understanding why some people experience high emotional sensitivity. The Kansas City psychiatrist joined KCUR's Up To Date on Tuesday.
AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD
With a detailed data drop that AstraZeneca’s R&D chief described as an internal “science success story,” the British Big Pharma has secured an FDA priority review for what it believes could become a flagship biologic in chronic obstructive pulmonary disease (COPD). In detailed results from the late-stage Oberon and Titania trials—first teased in March and detailed in full at the European Respiratory Society Congress in Barcelona this week—the drugmaker laid out the extent of its IL-33 inhibitor’s potential to reduce moderate and severe exacerbations in a wide range of COPD patients still struggling with those “lung attacks,” as AstraZeneca’s Sharon Barr, Ph.D., called them, despite using standard-care inhaled therapy. In the headline results, a 300 mg dose of tozorakimab given once every four weeks curbed those moderate and severe exacerbations in the studies’ primary population of former smokers by 29% in the Oberon study and 34% in Titania. In the overall population of both current and former smokers, these reductions were 30% and 29%, respectively, versus placebo and inhaled standard of care. The benefits also extended to clinically meaningful exacerbation reductions in all prespecified patient subgroups and specifically turned up promising signals in patients across a range of blood eosinophil counts, with Barr telling Fierce that “it’s the details that make this even more exciting than the high-level results that we’ve already shared.” In fact, during AZ’s tozorakimab poster presentation at the ERS 2026 Congress this past weekend, attendees were so enamored by the data that event organizers had to encourage people to clear the room and look at the other presentations on offer, Barr said in an interview. “I think it really speaks to the fact that there is a lot of buzz around these data because the entire respiratory community has been so desperate for new therapies for these patients,” she explained. The respiratory disease continues to represent a “staggering unmet medical need,” Barr said, highlighting the COPD exacerbations that the Oberon and Titania studies homed in on, which she added carry a greater mortality risk than a heart attack. “When a patient has a severe exacerbation, only about half of them are still alive within three and a half years,” she pointed out. As for tozorakimab specifically, Barr christened the molecule “an AstraZeneca science success story,” harkening several years back to the point at which researchers began to explore IL-33 as a driver of respiratory disease, and COPD in particular. At the same time, “there was still so much that wasn’t understood,” she admitted, highlighting the insight that IL-33 signals through both ST2 and EGFR through the RAGE pathway, a discovery Barr attributed to AstraZeneca's own scientists. Understanding the need to tackle both pathways in COPD—and aware of competitor candidates in the hopper, including one that bound ST2—the company ultimately had to make some “courageous decisions,” Barr said. These included taking a prior COPD molecule offline and going back to the drawing board to reinvent its potential IL-33 label “to make sure that we had a molecule that could block signaling through both arms of the pathway, through both the reduced form and the oxidized form, knowing that we wouldn’t be first, but striving to be best.” “When we put [tozorakimab] into the clinic, we firmly believed that we had a differentiated molecule, and we saw the other molecules blocking just ST2 or partially blocking IL-33, unable to deliver two positive pivotal studies in COPD,” Barr explained. “We kept marching forward because we believed our molecule was differentiated, and now I think we have the clinical validation that supports that.” Ultimately, AstraZeneca finds itself on much better footing these days when it comes to potential biologic rivals to tozorakimab in COPD. Sanofi and Regeneron’s Dupixent, for instance, is approved to treat COPD exacerbations in patients with high eosinophil counts, but not low ones. Meanwhile, the future has become cloudier for other next-gen IL-33 candidates from Sanofi and Regeneron, as well as Roche, which have suffered trial flops in recent years. One other potential ingredient for AstraZeneca’s success in its duo of studies was that the company was “ambitious in the trial design, willing to look at an all-comers population,” Barr said, “and willing to enroll the most severe patients.” Prior studies for would-be biologics rivals in COPD “avoided enrolling” those patients, she pointed out. She also highlighted the Big Pharma’s painstaking design of exacerbations in its trial, which “gave us a very rigorous readout,” and pointed to “the extra effort and investment” the company put in to understand the effect of mucus plugs in patients. Barr described mucus production as a “key feature in disease diversity,” noting that mucus plugs—obstructing clumps of mucus that block patients’ airways—are associated with worse outcomes in COPD. In its data announcement, AstraZeneca noted that an integrated analysis of Oberon and Titania found tozorakimab “demonstrated a reduction in patients’ mucus plug score,” with the pharma claiming its biologic is the first to deliver such results in a broad COPD population. “So being able to reduce those mucus plugs, we expect, is an important part of driving benefit for patients who are living with COPD,” Barr said. Again touching on the breadth of the study populations, Barr added that tozorakimab “worked across all eosinophil levels in both current and former smokers across all levels of lung function,” which she suggested “really simplifies decision-making for clinicians, and it allows them to offer therapy to the broadest possible patient population.” In the highest patient eosinophil count group, tozorakimab helped chart a 43% reduction in exacerbation risk, which Barr stressed were “unprecedented data.” In the mid-level group, AZ’s drug delivered a 23% reduction and, in the lowest group, a 34% reduction in eosinophils, which Barr said suggests efficacy “in all patient subgroups.” As for AZ’s recent guidance upgrade on the medicine’s sales opportunity, the lift from a $3 billion to $5 billion range to $5 billion plus was informed by multiple factors, Barr said, including the fact that “in 2024, there were multiple competitors, and there aren’t anymore.” Additionally, “we know that this is a massive unmet medical need, and this is a really incredible set of data that we think will be very convincing to the clinical community,” Barr said. Looking ahead to a potential evolution of the COPD treatment landscape, Barr noted that most patients start treatment in the community with an option like a triple therapy, and for them, having an option like AstraZeneca’s inhaler Breztri will remain a “really important part” of that journey. But of the patients uncontrolled on triple therapy, which Barr described as “about half of them today,” just a “small fraction” are currently eligible for biologic therapy, which she emphasized AstraZeneca is working to change. Understanding that COPD is not a “one-size-fits-all” disease, AstraZeneca is also looking at its antibody drug Tezspire for patients with T2-driven disease, and the company continues to think about new mechanisms for tackling COPD through both systemic and inhaled drugs, Barr said.
Williams warns WRU on 'almost non-existent' student support
Former Wales and Lions wing Shane Williams says pathways support for schools and colleges from the Welsh Rugby Union (WRU) is 'almost non-existent'.
Ozempic and Wegovy may have an unexpected mental health benefit
Semaglutide, the drug behind Ozempic and Wegovy, may have benefits that extend well beyond weight loss and diabetes. In a large Swedish study of nearly 15,000 people with bipolar disorder, its use was linked to a 21% lower risk of psychiatric hospitalization. Researchers think effects on inflammation and brain-related biological pathways could help stabilize mood, though other GLP-1 drugs did not show the same association.
Cardinals’ 3rd-base Picture Coming Into Focus for 2027
After the offseason exits of Nolan Arenado and Brendan Donovan from the Cardinals organization, it opened up a pathway for Nolan Gorman to take advantage of everyday opportunities. However, that hasn’t quite come to fruition. The Cardinals optioned Gorman to Triple-A Memphis in June and put him through a vigorous rework of his swing and […]
A 300,000-year-old jawbone from China refuses to fit neatly into the human family tree — and a reconstructed million-year-old skull is now suggesting our major ancestral branches split hundreds of thousands of years earlier than we thought
The fossil record is forcing scientists to rewrite when and where human ancestry split into separate branches, upending decades of assumptions about our evolutionary path.
Researchers identify new therapeutic target for salt-sensitive hypertension
The researchers discovered that a signaling pathway called AP-1 complex links dietary sodium to immune-driven salt-sensitive hypertension.
Gmail change may flood your inbox with political email
Gmail's Verified Sender Program launches September 8, 2026, giving U.S. political committees a more reliable path to your personal email inbox.
Commission to present long-awaited Innovation Act proposal
The European Commission will present its proposal for an EU Innovation Act on September 9, with a focus on strengthening public procurement as a driver of innovation and facilitating the use of intellectual property (IP) to secure financing.The proposal was initially meant to be published in March. No explanation has been given for the delay, but it may be linked to issues with the associated impact assessment.The Commission’s Regulatory Scrutiny Board issued a negative opinion on the draft impact assessment following its meeting on January 28, and again on February 27, according to a draft of the Innovation Act published by Agence Europe.In it, the Commission lays out the steps it has taken to address the board’s concerns, including avoiding overlap with the upcoming revision of the EU Public Procurement Directives and removing a mandatory target for EU member states to increase overall innovation procurement spending.The Innovation Act, which was included in last year’s start-up and scale-up strategy, is meant to reduce barriers to bringing innovative solutions to the market and speed up the path from research to commercialisation.Central to the initiative, according to the draft proposal, is the introduction of a harmonised EU framework for the procurement of R&D services by public buyers, including pre-commercial procurement. The plans would also introduce an EU preference in public R&D procurement.“Other leading economies in the world are investing five to eight times more in public procurement of R&D than the EU,” it notes. In Europe, the lack of harmonised rules has led to divergent practices across the bloc, legal uncertainty and limited use of joint, cross-border R&D procurement, it says.Related articlesCommission postpones European Innovation ActParliament draft report adds EU Inc safeguards to prevent fraud and regime shoppingThe text highlights a lack of clarity around the valuation and monetisation of IP as another barrier to the commercialisation of research results. Currently in the EU, IP is rarely used as collateral in financing, which restricts the growth potential of innovative firms. A key reason for this, according to the Commission, is the absence of a harmonised methodology for valuing IP.To address this issue, it plans to introduce an EU-wide IP valuation framework, a digital marketplace for commercialising IP, and a competence centre to help innovators access IP-backed finance.The issue was highlighted by a recent report by the European Union Intellectual Property Office, which referred to developing a “functional market for IP-backed finance” as a “core competitiveness imperative for the next decade,” and key to ensuring capital unlocked by other EU initiatives reaches innovative firms.The Innovation Act is one of several ways the Commission hopes to reduce fragmentation in the single market and help innovative companies to scale in Europe, complementing other initiatives such as the EU-wide corporate regime, dubbed EU Inc.The leaked draft is not the final version that will be published on September 9, according to a Commission official.
Democrats try a novel path to defeat a battleground Republican: Moving to the left
Antiestablishment candidate Randy Villegas is testing the conventional wisdom about what it would take to unseat Rep. David G. Valadao in California.
UNC to hold community summit on mental health and suicide prevention in Raleigh
The UNC Suicide Prevention Institute is inviting community members to join the “Path to Prevention: Foundations for Suicide Prevention Summit” on Thursday, Sept. 17, from 9 a.m. to 3 p.…
Venice 2026 Film 'Ground Floor' Is a Political Parable on Apathy: Clip
Hungary's Gábor Reisz, winner of the 2023 best film award in Venice's Horizons section for 'Explanation for Everything,' returns to the Lido in the Venice Spotlight program with a quixotic tale and dark humor.
How Mental Health Influences Bladder Function and Lower Urinary Tract Symptoms
Lower urinary tract symptoms are closely associated with anxiety, depression, chronic stress, and broader psychosocial burden, with evidence suggesting complex interactions between psychological state, sensory processing, stress pathways, and bladder function. Although some relationships may be bidirectional, current evidence does not establish a universal causal pathway, reinforcing the importance of integrated assessment and management.
Cuba: US Embassy issues health alert due to GI pathogens like norovirus, Shigella
The US Embassy in Havana issued a health alert last week after seeing a significant increase in diarrheal illness across Cuba, associated with the continuing degradation of the water and energy infrastructure. This degradation affects water supply, and food storage and temperature control. Recent cases have included E. coli, norovirus, Shigella, and other gastrointestinal pathogens. This comes after a health alert dated August 28 which noted that Cuba’s water delivery infrastructure is increasingly unstable. The Embassy is aware of reports of residential neighborhoods that have gone for long periods without receiving water from municipal or public sources. Dengue cases surge in the Tampa Bay area Prolonged and worsening water issues and power outages caused by the regime’s mismanagement of public infrastructure impact the entire island. Water often only flows to residences when city power is on for a sufficient amount of time. Media reports indicate wells are running dry across the country due to drought, aggravating the ability to supplement water delivery. The lack of water, coupled with power shortages that have disrupted cold chain networks, can present significant health and safety challenges. We remind U.S. citizens to be aware of the risks when traveling to Cuba and take precautions. Embassy officials offer the following precautions to prevent illnesses: Avoiding Foodborne Illness: Be cautious of meat, poultry, seafood, eggs, dairy, and other perishable foods that may have been inadequately stored. Avoid foods that appear to have been sitting at room temperature for extended periods. Avoid raw or improperly washed vegetables. Be cautious of food cooked and then cooled, stored, or reheated, as improper temperature control can allow pathogens or toxins to develop. Wash hands thoroughly with soap and water before eating and after using the restroom. Hand sanitizer may be less effective against certain gastrointestinal pathogens, including norovirus. Outbreak News Today is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe Water Safety: Use only water known to be safe for drinking, brushing teeth, making ice, and cooking. Use bottled or appropriately treated water; check that bottle seals are intact before opening. Avoid ice unless the water source is known to be safe. Do not use untreated tap water to prepare beverages or food. Be aware that contamination can occur when food, utensils, and surfaces are washed with contaminated water. If You Become Ill: Stay hydrated, especially with frequent diarrhea or vomiting. Most illnesses are self-limited and improve within several days. Seek medical attention for persistent or severe diarrhea, bloody stools, high fever, significant abdominal pain, repeated vomiting, signs of dehydration, or symptoms not improving. Common medications (e.g., acetaminophen, ibuprofen, antibiotics) are frequently unavailable in Cuba; consider bringing your own supply. If you like the reporting on Outbreak News Today, please consider a paid subscription for $5/month or $30 a year. Help support the cause of this niche journalism. It is appreciated.
Buccaneers Have 22nd-Hardest Strength of Schedule in 2026
A favorable path emerges for Tampa Bay as a healthy roster and a vulnerable NFC South provide the perfect opening to reclaim the division throne this season.
Exclusive: Fetterman blasts ‘disgruntled staffers’ and ‘smears’ after report details apathy toward his work
Sen. John Fetterman is lashing out at former aides who accused him of showing indifference toward his work and of routinely skipping constituent meetings, dismissing them as “disgruntled staffers” pushing “smears” to tarnish his reputation.
‘What a Coward’ — Barstool Sports CFB Analyst Trashes Dave Portnoy After Michigan’s ‘Unbelievably Pathetic’ Week 1 Win
The college football world witnessed a stunning and wildly controversial finish between Western Michigan and Michigan on Saturday night in Ann Arbor. Despite Western Michigan holding a 12–7 advantage with less than a minute remaining, a highly debated officiating decision ultimately changed the course of the game and swung the momentum back toward Michigan at the very last second.
Could Better Mental Health Start With the Gut? Scientists Found Specific Pathways to Test
A study of 61 healthy women found region-specific associations between microbial pathways, brain chemistry, anxiety, depression, and sleep quality.
In praise of the high number
It’s not gonna last, but the kids carving their own path is fun
Essentia Health-Duluth Clinic welcomes physiatry specialist Dr. Christine Tenhoff
Dr. Christine Tenhoff, a doctor of osteopathic medicine specializing in physiatry, is thrilled to join the Essentia Health-Duluth Clinic.
Gamescom apologises for how it initially responded to indie developer hardware thefts
Gamescom has apologised for its initial response to hardware thefts affecting indie developers, admitting it didn't show the empathy people deserved.
Weak hydrogen bonds dethrone copper as the most stable metal binder, opening a new path for metal selection
- KAIST researchers reversed a decades-old metal-complex stability trend by tuning weak hydrogen bonds around the complexes without altering the metals’ direct coordination environments - The discovery could provide new design strategies for selective metal separation and recognition, catalysis, and biomimetic systems
Here's what you need to know about breaking mental health stigma
Uncover essential facts about breaking mental health stigma. Learn how understanding can lead to empathy and societal change. Read more today.
Science Hill Transition School to Work provides pathway for students with special needs
JOHNSON CITY, Tenn. (WJHL) — Science Hill High School’s Transition School to Work (TSW) program is already showing strong signs of success. The program is designed to provide students with sp…
Armor Health and the Stark County Sheriff's Office Partner in Launching PATH Program at Stark County Jail and Celebrate First Graduates
/PRNewswire/ -- Armor Health (ArmorHealthcare.com), a national provider of correctional healthcare, has launched the Prevention, Accountability, Treatment &...
I could see my kids' future careers before they were 10
Looking back, I can see signs of my five kids' future careers in their childhood interests. I'm glad I supported them without forcing a path.
Lakers Champion Gives Verdict on LeBron James' 76ers Future
LeBron James is entering a part of his career he has never quite experienced before. At 41, with his 24th NBA season ahead of him, the four-time champion has taken a much different path into the next chapter than he has at any point since entering the league.
Where do the LA Clippers go from here?
There is a path forward, but the coming years are not going to be pretty.
Three Louisiana brands, three paths to growth
Before Slap Ya Mama seasoning landed on grocery shelves in all 50 states, and eventually reached markets as far away as Dubai, the Walker family mixed its seasoning in a glass pickle jar at its Ville Platte convenience store. As Business Report writes in its latest issue, what started as a homemade blend sold in […]
From Science to Soil: Emily Fulstone Honors History Through Environmental Innovation
By blending environmental science with time-honored ranching traditions, this Smith Valley producer is proving that regenerative agriculture is the path forward.
Fired by Turner Sports, Erin Andrews Doesn’t Hold Back on ‘Terrible’ Stint as MLB Reporter Before ESPN & FOX Roles
Sportscaster and journalist Erin Andrews’ path to becoming one of the most recognizable faces in sports television was not nearly as smooth as it looks in hindsight. Before ESPN, FOX Sports, Super Bowls, and years on the NFL sideline, Andrews had a short stretch at Turner Sports that ended with the network letting her go.
Judge clears path for LSU to add former NFL players to roster
A Louisiana judge has cleared the path for Louisiana State University to add former NFL players to its roster. This comes just hours after the SEC filed a lawsuit against LSU and head coach Lane Kiffin.
Notes From Political No-Man's Land
Here I find myself, in political no-man's land, crouched behind a garbage can, keeping my head down while verbal bullets fly overhead - "fascist" from one side, "toxic empathy" from the other. Socrate...
'By Any Means' review: Mark Wahlberg takes the Johnny Depp path
Imagine "Mississippi Burning" meets "Green Book."
Ohio State Lima Announces 1+3 Horticulture and Crop Science Pathway
LIMA, Ohio — The Ohio State University at Lima will soon offer the foundational coursework for Horticulture and Crop Science to students interested in working...
Meloni breaks Italy’s post-war political record
Faltering reforms and a growing nationalist right could complicate the prime minister’s path to re-election
Nurses announce sympathy strikes, pickets on Sept. 15 at five Prime Healthcare hospitals in four states
RNs at two Prime Healthcare hospitals in Nevada and California and nurses and health care workers at a Prime facility in California gave notice that they will hold a sympathy strike for one day on September 15 in solidarity with striking nurses at Olympia Fields Hospital in Chicago, Illinois. Nurses at another Chicago hospital and at a hospital in Lewiston, Maine, will hold informational pickets in solidarity with Olympia Fields RNs on the same day.
Honors, UNMC host students for spotlight on behavioral health careers
Healing Nebraska: Talent Meets Need was held in partnership with The Foundry and gathered 200 University of Nebraska–Lincoln students to discuss community behavioral health needs and career pathways.
Global warming will exceed 1.5-degree limit, UN says in report that maps path back below danger zone
In a strategic retreat in the fight against climate change, the United Nations has acknowledged that Earth has lost its chance to prevent some of the worst of global warming's harms. So now the world must figure out how to get temperatures below the danger zone and back to safety, officials say.
Letting You Be A Complete Psychopath Reveals The Scale Of Fable's Ambition
Playground Games talks about the scope and limits of its fantasy RPG simulation
Fort Wayne business holds dedication ceremony for beautification project along Pufferbelly Trail
Overhead Door of Fort Wayne unveiled a creative display of 8-ft-high banner sections that decorate 200 feet of fence bordering its Keystone Drive location and the pathway.
UWM helps student grow her love of science
In high school, a research project into a type of virus helped stir Ally Ruffino’s love for science. In college, she discovered a professor who worked with that same virus, and it spurred her into an academic path she loves.
Halloween Cleverly Carves Its Own Path Through Horror Multiplayer
Michael Myers comes alive in IllFonic's latest asymmetrical haunting grounds.
FDA pilot offers generative AI medical devices a path to patients before they are authorized
AI products from Cadence and Limbic are among four devices recently accepted into the FDA’s TEMPO pilot that will allow digital health companies to release products without marketing authorization.
3 farmers, 3 paths to better soil health
From organic rotations to no-till corn, these farmers share the practices they've tested, the results they've seen and what they'd change.
Changes to Medicare’s quality payment program may disadvantage radiologists
CMS is moving to new MIPS Value Pathways, or MVPs, which are specialty-specific measures intended to replace traditional ones, experts write in JACR.
How to Solve the Parks Festival Quiz Puzzle (Parks Floating Festival) - Disney Dreamlight Valley Guide
The Parks Festival Quiz Puzzle is one of the final puzzles introduced to the Parks Floating Festival event in Disney Dreamlight Valley. It debuted on September
'A clarity of path': Farhan Zaidi talks future of Los Angeles Sparks
Basketball Insider Howard Megdal sits down with Farhan Zaidi for an exclusive interview about the path forward for the Los Angeles Sparks.
McKenzie Siroky was a rising hockey prospect. Now she’s on an Olympic path in swimming
Siroky was committed to a top school and had big hockey dreams, then she gave it all up for swimming. Now she's one of the world's best.
Joel Klatt wanted to be the ‘next Kirk Herbstreit.’ Klatt may have surpassed him
Fox's lead college football game analyst had a non-traditional path to the top of his profession. He's also got ideas how to fix the sport.
Skip Bayless Criticizes ‘Outrageously Wrong’ Shedeur Sanders Situation
Skip Bayless believes Shedeur Sanders has been placed in an unfair situation with the Cleveland Browns, and the outspoken sports commentator did not hold back in his latest criticism of the organization. Bayless described the quarterback’s circumstances as outrageously wrong after another development complicated his path to meaningful playing time. Sanders entered the 2026 season […] The post Skip Bayless Criticizes ‘Outrageously Wrong’ Shedeur Sanders Situation appeared first on Gridiron Heroic
August Monthly Review: ChatGPT In Epic
Death, taxes, another frontier lab healthcare launch inspiring truly insane LinkedIn takes. As much as I want to stay away, I repeatedly am the crewman unplugging his ears whenever we pass these sirens. So it’s not the first and probably not the last time we dial up the typewriter rather than tie ourselves to the mast. The full blow-by-blow timeline: Health API Guy is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe The End of the Standalone PHR (Jan 8): ChatGPT Health arrives for consumers, at the time powered by b.well. I was bullish on the approach in that the best way for the PHR to finally solve distribution was to meet consumers were they already are (i.e. When Horizontal Meets Healthcare (Jan 9): OpenAI for Healthcare puts out the shingle for enterprises, with SharePoint ingestion standing in for the EHR integration the product actually needed. Another One: Anthropic’s Healthcare Debut (Jan 16): Claude's version, on HealthEx rails instead of b.well, with Agent Skills for FHIR development as the one true vertical-specific investment. ChatGPT for Clinicians: The Trap Sprung (Apr 24): OpenAI filled in the missing GTM middle with a free product for verified clinicians, effectively peeling the enterprise wrapper off ChatGPT for Healthcare and taking the PLG fight directly to OpenEvidence. OpenAI’s Second Attempt at Health (Jul 31): a relaunch of their patient specific app, now branded Health in ChatGPT, where the privacy partition came out, the connectors thinned, and b.well disappeared in favor of first-party FHIR work against a smaller network Beyond a Shingle So what was announced now? Today, we’re introducing a new electronic health record integration that brings authorized patient context from Epic into ChatGPT for Healthcare, along with the Healthcare Public Data plugin for direct, structured access to official healthcare datasets like PubMed, DailyMed, and CMS Coverage. Together, these capabilities bring ChatGPT closer to the systems and sources healthcare teams trust, while supporting the controls and compliance healthcare work requires. The core portfolio is unchanged from prior announcements we delineated and discussed (aside from the relaunch of patient-facing). Since trade publications still seem to be confusing them by using the wrong names: Enterprise sales motion: ChatGPT for Healthcare Protecting their core product / PLG: ChatGPT for Clinicians Consumer/patient-facing product: Health in ChatGPT So really, this is a feature release (specifically for ChatGPT for Healthcare when it comes to EHR integration). What’s cool about it, though, is that we are moving beyond just putting out a shingle. Everything in the January enterprise launch was horizontalizable: Horizontal tech companies thus generally start verticalization with their “putting out a shingle phase”. Telling the world you’re open for business as a horizontal tech company reliably attracts early inbound interest from buyers who are already trying to force-fit horizontal tools into domain-specific workflows and are eager for any signal that the vendor intends to support their use case more directly. Nothing was really vertical specific, which is exactly what you'd expect from the ultimate hypergrowth horizontal company dipping their toes into specific industries. But eventually you have to stop changing the sign on the door and start changing the product. Can you guess where the horizontal product was going to run out of road? This is the core dilemma writ large: verticalization requires differentiation, while scale economics of consumer and horizontal push toward unification. I’ve buried the lede so deep here it will be painful to some readers, but what should be shocking to no one is that my perspective is that EHR integration is the only path that meaningfully resolves this tension for ChatGPT for Healthcare. Integration with Microsoft Sharepoint is fine, but it is categorically insufficient for any product that hopes to influence clinical decision-making. SMART Money Well here we are, eight months later! Real vertical investment has begun, which surprised a few people. One friend in the industry messaged me: “Absolutely no way Epic gave ChatGPT API access.” Looking forensically at the announcements, the integration is notably read-only across appointment notes, laboratory results, medications, and specialist documentation. So while I’m not a betting man, I'd wager the house this is a SMART on FHIR launch: That sounds a lot like USCDI! The recommended path for the workflow they outline would be SMART on FHIR Their Health AI lead’s post is evocative of both standalone and EHR launch SMART, which another termed “ChartGPT” and “EHR Plugin” The implementation burden for SMART on FHIR is the lowest of the available integrative paths This is the team who literally did patient-facing SMART on FHIR with Epic last month Most importantly, if you’re a horizontal company, you generally still haven’t taken the full plunge and thus (overly) value reusability. SMART on FHIR is the logical compromise: healthcare-specific enough to matter, but standardized enough to reuse. Nobody Asked Judy Another friend asked “I thought they had to go to each health system, or did they go direct to Epic and now health systems opt in?” Given the trust paradigms in healthcare, this functionally cannot be Epic hoovering up all the data for OpenAI and shoving ChatGPT in their customers’ faces (or they would revolt). However, I do believe the aforementioned terrible coverage by TechCrunch and other outlets is probably responsible for that question, given the 325 million reference. When using FHIR as a business associate to an Epic customer, there is no EHR gatekeeping to speak of, as that isn’t how fhir.epic.com works: You register an app You pick your APIs You test against the sandbox APIs You list as “Ready for Production” Hospitals pick your app You test and go live with them Bluntly, nobody had to say yes or no in Verona (nor were they given the chance). Vendor Services (their next developer tier up that I doubt OpenAI is using quite yet in this initial release) certainly has contractual paperwork that some resent, but even there, the twin pressures of mounting antitrust and information blocking make outright gatekeeping increasingly fraught. My friend’s sentiment is, to me, representative of a broader industry neurosis, perhaps a sort of scar tissue of prior eras: people assume the gate is still there and never actually try the door. There are certainly other ways Epic (and any EHR) can put its thumb on the scale, but they are not so dumb as to stand in front of a federally mandated API and play bouncer at this exact moment in time. So I think they can and probably should go deeper, as this release is at best parity and at worst behind vertical-specific competition. OpenEvidence did a basic SMART launch with Sutter Health in February, allowing for more convenient evidence search by providers. They then add patient-context (the equivalent SMART on FHIR flow to what we see here) when Cedars-Sinai went enterprise-wide in May. UpToDate has four distinct applications across deeper workflows like patient engagement listed in Epic Showroom and announced a partnership with Epic to power Art at UGM Abridge and other ambient scribes have invested deeply into the deepest bidirectional clinical copilot workflow with integrations well beyond SMART on FHIR. In that light, the “Who is OpenAI primarily targeting here?” is clear. This release brings them into striking distance of OpenEvidence, but not the others quite yet. They are the only one of the three you can reach without building something truly Epic-specific. When will they go further? Competition is a great motivator to overcome the horizontal demons and start building things that can’t be reused: not across industries, not across EHRs, maybe not past the customer you built them for. That’s the price of actually verticalizing. The question is if and when OpenAI will be willing to pay it. Month in Review Here is the monthly review. As a reminder, this is a regular round-up of the month’s posts and other content to surface things you may have missed across regulation, litigation, interoperability, and beyond. AI assistance is used in these bullet summaries so I can focus on articles. Articles Published: None this month Video Content: The Information Exchange: Standards-based Thruple Edition (Aug 14): Back to school for us too, with Brad reporting in from the CMS Health Tech Ecosystem’s one year anniversary in DC. We get into the January CMS-0057 deadline, the fall rulemaking reading list, and why enrollment still keeps most apps off FHIR. The Information Exchange: Epic Dúnadan Edition (Aug 25): A UGM roundup with Ryan Brickner joining for the first time to check our takes against what the building actually thinks. Rangers, Ergo sitting on top of EHI, and a down-market lineup that needs some cuts. Regulatory: Stacked Deck, Bad Hand (Aug 05): ONC’s website refresh took the entire HIT Policy Committee record with it, so I rebuilt the archive and went looking for the regulatory capture story everyone assumes is buried in there. Stacking the deck and winning the hand turn out to be very different things. The Sixth Generation of Patient Access (Aug 19): A quick catalog of the five generations of patient access we’ve layered on since HIPAA, and the two candidates now competing to be the sixth. One is planned. The other is the market routing around the plan entirely. Court cases: Three Cases Walk Into a Docket (Aug 06): Two surprise settlements cleared the board in a single week, and then Judge Maddox dropped ninety-four pages on Vyne v. Henry Schein. The sleeper is a DMCA holding that makes direct-to-database a considerably riskier business model. Epic v. Health Gorilla: Into the MDL (Aug 10): Nine class actions are headed to Miami, and the Panel signaled it wants to bring the case that spawned them along too. That would leave Epic arguing the requests were obviously fraudulent in one courtroom and unknowable in the other. Amazon v. Perplexity: Agents Are Legalized! (Aug 11): The Ninth Circuit vacated the injunction against Comet, holding that the user is the one accessing the servers rather than the company that built the agent. A real win for agentic access, and a much narrower one than the headline suggests. Veeva v. Epic: Come At Me, Bro (Aug 26): Epic’s response brief wants the dismissal affirmed and, unusually, wants the opinion published as precedent. Buried in it is Epic’s own description of what its non-competes actually prohibit, which current and former employees should read closely. EHRs: The Contract Epic Would Never Sign Today (Aug 04): A 1999 SEC exhibit catches Epic licensing nearly its entire product line, Tapestry included, to the company that became TriZetto. The marketing services menu attached to it is the part that will make you blink. Forecast from Verona (Aug 07): The Epic Almanac makes one argument six different ways: the AI is only as good as the networks behind it. Emmie headlines, Art’s context stack is the most ambitious part, and Penny finally gets an autonomous coding date on the calendar. Works With Epic MyChart (Aug 17): Epic’s first new Showroom category since the death of Workshop certifies hardware instead of software, badge on the box and all. Made for iPhone, but for blood pressure cuffs, and rough news for anyone selling the RPM stack sitting in between. UGM Hot Takes 2026 (Aug 20): Everyone else covered the AI announcements, so I went after Savvy deleting the payment gateway, Rangers as Boost with the timer removed, and a down-market lineup with too many entries. Plus the Health Grid tidbits I cannot help myself on. MyChart Central Grows Up (Aug 24): Device data and Emmie turn Epic’s identity hub into a full consumer platform, which is both a logical answer to ChatGPT and a bit of a mistake. It also happens to be the best scraping target Epic has ever shipped. Industry Analysis: The Wrong Yardstick (Aug 12): Vertical software keeps getting judged against Superhuman and Notion, which is the wrong bar entirely. Your user is comparing your product to a whiteboard and forty phone calls before lunch. Primitives vs. Abstractions (Aug 27): Developers want building blocks, systems of record prefer to hand out business logic, and both sides have a real case. There’s no test from the outside that separates the engineering reason from the competitive one, which is why this keeps ending up in court. Cross-industry Comparisons: The Two Kinds of Platform Power (Aug 18): Attention power and record power are different problems that keep getting handed the same regulatory toolkit. Congress’s latest swing at Big Tech shows both what’s possible and where it falls apart. The Dogs of (Platform) War (Aug 21): A CourtListener alert turned up a property management fight with healthcare’s exact shape and none of the Cures Act. Shell prospects, ghost accounts, a notetaker bot that came back to haunt someone, and a lawyer arguing both sides of the same theory in two states. Fractals All the Way Down (Aug 31): Yardi dominates property management right up until you zoom into one segment, where AppFolio owns it outright and Yardi doesn’t appear at all. Where you draw the line around a B2B software market is about to decide an awful lot of cases. Other News: If Judy Had the Courage (Aug 13): A short eulogy for the era when software was allowed to look insane: WinAMP, bold colors, and everything the grey chatbot era has taken from us. External Media: Portland Monthly Health Tech Meetup: Erin O’Brien channeled my own feelings - maybe it’s just because it’s August and beautiful, but the monthly edition of the PDX Health community meetup was a ripper. Make sure to reach out if interested to join for the next one. STAT’s Coverage of Epic This Month: Brittany Trang of STAT did a fantastic job of breaking the FTC investigation that’s been lurking, as well as UGM related coverage, so I had to give her her wish of a meme. Fall Conferences: I’m pumped to be kicking off my fall conference season in NYC at Nabla Accelerate next month, which Chrissy provided the link to apply for. Here’s the rest of my schedule in case you want to meet up: Commonwell (Redwood Shores, CA): Oct 13-14 Open@Epic (Madison, WI): Oct 21-22 eHealthExchange (Austin, TX): Oct 27 Sequoia Project (Austin, TX): Oct 28-29 HLTH (Vegas): Nov 15-18 RSNA (Chicago): Nov 29-Dec 3 Posts I Liked: HTI-6 Should Unbundle API Certification: Josh Mandel makes the case that HTI-6 should split (g)(10) into separate authorization and data certifications, so a PACS or a genomics platform can certify only the role it actually performs. Imaging is the urgent example, but the structure solves a much bigger problem. On implementing ePrior Auth with Epic: Scott Rossignol’s field notes from a live ePrior Auth build on Epic, including the two app registrations nobody warns you about and the CPT mapping problem waiting at the end. CMS-0057 implementations are going to be such a beast. Healthcare point solutions are starting to look a lot like streaming services: Spencer Dorn runs the cable-to-streaming arc against health IT and lands squarely on the bundling half of the cycle. Bundling can be good! It can also be bad! Life is nuanced. Health API Guy is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
The Future of Lymphoma Care Is Moving Forward With Science | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
House sends government funding bill to Trump to avert shutdown ahead of midterms
The House passed a bill on Tuesday to extend government funding to December 11, clearing a path to avert a shutdown ahead of the upcoming midterm elections.
Study Identifies Potential Therapeutic Target Protein that Drives Metabolic Liver Disease Independent of Diet
The protein appears to cause liver damage by triggering an out-of-place antiviral immune response. Blocking this pathway can protect against liver injury in human cells and mouse models, even on a high-fat diet—paving the way for therapies to prevent liver damage.
PRESS RELEASE: NETEC Announces Second Round of NSPS Level 2 STAND Award Recipients to Strengthen Special Pathogen Preparedness Nationwide
National Emerging Special Pathogens Training and Education Center
UCLA parts ways with AD Martin Jarmond, brings in former Lakers exec Tim Harris
In announcing move, Chancellor Julio Frenk called the current financial path of UCLA athletics "not sustainable."
AI tech uses cardiac CT scans to evaluate inflammation, predict stroke risk
AI technology developed by Caristo Diagnostics was the focus of multiple studies presented at ESC Congress 2026.
How NJ's Largest Health Network is Fixing an $8B National Crisis in Parkinson's Care
Hackensack Meridian Health has developed an innovative Parkinson’s Disease Care Pathway integrated directly into its electronic health record system.
Meet the Newest Members of Poole’s Graduate Business Community
This fall, 291 students joined Poole College of Management’s graduate business programs, bringing experience from fields including technology, education, accounting, marketing, financial services and the military. Meet six incoming students and learn about the paths that led them to NC State, what they hope to gain and where they plan to go next.
- Gary W. Rollins College of Business
Trey White, a 2004 Rollins College of Business accounting graduate, shares how UTC, a defining EY interview, and a mentor shaped his path to CFO.
Politics, Pubs, Parades, + the Parish: Jim McGreevey, Part 2
McGreevey traces his path from the Middlesex County Prosecutor’s Office to the New Jersey Assembly, Woodbridge mayor’s office.
The curious case of Sam Bankman-Fried's friends' Anthropic shares
Sam Bankman-Fried's Anthropic stake was liquidated in bankruptcy court two years ago. His friends' shares went down a different path.
Together, GLP-1s And GenAI Can Solve Healthcare’s Affordability Crisis
Two innovations offer a new path to healthcare affordability: GLP-1 medications and generative AI. Here's how to two could radically improve medicine and lower costs.
31-year-old millionaire has zero sympathy for unemployed Gen Z’s ‘excuses’—he says ‘it is scarily easy’ to build a business and get rich right now
As AI kills entry-level jobs, multimillionaire Timothy Armoo has a blunt message for unemployed Gen Zers: stop making excuses and start building.
Lummi Nation offers model for county's path to behavioral health, justice
Appropriate behavioral health care should be at core of mission to deliver justice
Vanderbilt University Medical Center sued after allegedly exposing dozens of patients to bloodborne pathogens
Many of the details are unknown, but a primary plaintiff in the lawsuit said the exposure stemmed from a contaminated solution used during a 2024 colonoscopy. An attorney representing the patient said as many as 100 people could have been exposed to bloodborne pathogens.
Moussa Diabate gets a reality check from former Knicks head coach Tom Thibodeau
Moussa Diabate might have missed an opportunity, but he is already thriving after taking the hardest path.
Scientists find why the liver may not heal even after you stop drinking
Alcohol-related liver disease may trap damaged liver cells in a regenerative limbo, preventing the organ from rebuilding itself even after drinking stops. Researchers linked the problem to inflammation-driven RNA errors and identified a pathway that could potentially be targeted to restore liver repair.
Democratic Senate control has moved from a reach to a toss-up
The four-seat gain Democrats need to win control once seemed all but out of reach. Odds are looking up, though the party still faces a tough path, with toss-up races in a half dozen (mostly red) states.
Luzerne County Council zeroes in on inmate health care practices
Luzerne County prison inmate medical care procedures and costs were discussed at length during last week’s County Council work session.
Jordan Clarkson crossed paths with rising tennis star …
Jordan Clarkson crossed paths with rising tennis star …
This Iowa Democrat is stirring hopes of a red state comeback by charting his own path
Iowa has not elected a Democratic governor since 2006, but Rob Sand’s candidacy and his congenial approach to politics has stirred a sense of optimism for the party.